NCT00199407View on ClinicalTrials.gov

A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa

PHASE3CompletedINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

November 30, 2005

Study Completion Date

January 31, 2006

Conditions
Parkinson's Disease
Interventions
DRUG

Istradefylline (KW-6002)

Trial Locations (1)

08540

Kyowa Pharmaceutical Inc., Princeton

Sponsors

Lead Sponsor

Kyowa Kirin, Inc.
All Listed Sponsors
lead

Kyowa Kirin, Inc.

INDUSTRY